INTERNATIONAL PATENT: NIKANG THERAPEUTICS, INC. FILES APPLICATION FOR "BIFUNCTIONAL COMPOUNDS CONTAINING 2,5-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 AND/OR CYCLIN-DEPENDENT KINASE 4 VIA UBIQUITIN PROTEASOME PATHWAY"

GENEVA, Nov. 25 -- NIKANG THERAPEUTICS, INC. (200 Powder Mill Road, Bldg E500Wilmington, Delaware 19803) filed a patent application (PCT/US2025/029225) for "BIFUNCTIONAL COMPOUNDS CONTAINING 2,5-SUBSTITUTED PYRIMIDINE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 AND/OR CYCLIN-DEPENDENT KINASE 4 VIA UBIQUITIN PROTEASOME PATHWAY" on May 13, 2025. With publication no. WO/2025/240536, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YU, Zhiyong (c/o NiKang Therapeutics, Inc.200 Powder Mill Road, Bldg E500Wilmington, Del...